Concepedia
Statistics
Publications
10
Citations
236
H-Index
Active since
2015
Affiliations
University Hospital Cologne(Current)
Heinrich Heine University Düsseldorf
University of Cologne
Düsseldorf University Hospital
University Hospital Ulm
Adam Giza is an author at University Hospital Cologne specializing in oncology, medicine, and immunotherapy.
Publications per year
2015–2025
Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/<i>TP53</i>mut
H. Huber, Eugen Tausch, Christof Schneider et al. · Blood · 2023 · 48 citations · Full text
Medicine, Oncology, Pharmacology +11
The Factorial Survey: The Impact of the Presentation Format of Vignettes on Answer Behavior and Processing Time
Hawal Shamon, Hermann Dülmer, Adam Giza · Sociological Methods & Research · 2019 · 29 citations
Education, Educational Psychology, Psychology +8
Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies
Petra Langerbeins, Adam Giza, Sandra Robrecht et al. · Blood · 2024 · 28 citations · Full text
Medicine, Immunology, Oncology +12
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
Johannes Bloehdorn, Andrejs Braun, Amaro Taylor‐Weiner et al. · Nature Communications · 2021 · 26 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax
Moritz Fürstenau, Jonathan M. Weiss, Adam Giza et al. · Clinical Cancer Research · 2022 · 26 citations
Medicine, Hematology, Oncology +17
1–5 of 10